ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 96 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $220,393 | -60.7% | 299,004 | -32.7% | 0.00% | – |
Q2 2023 | $560,110 | +361.2% | 444,532 | +164.7% | 0.00% | – |
Q1 2023 | $121,436 | -26.1% | 167,942 | -45.9% | 0.00% | – |
Q4 2022 | $164,415 | -56.3% | 310,490 | -31.6% | 0.00% | – |
Q3 2022 | $376,000 | -40.4% | 453,900 | -21.6% | 0.00% | – |
Q2 2022 | $631,000 | -22.8% | 578,652 | -11.4% | 0.00% | – |
Q1 2022 | $817,000 | -75.9% | 653,446 | -69.1% | 0.00% | – |
Q4 2021 | $3,384,000 | -60.5% | 2,115,888 | -19.4% | 0.00% | -100.0% |
Q3 2021 | $8,562,000 | -81.5% | 2,626,516 | -64.1% | 0.00% | -83.3% |
Q2 2021 | $46,250,000 | +1477.4% | 7,317,977 | +426.6% | 0.01% | – |
Q1 2021 | $2,932,000 | +793.9% | 1,389,556 | +301.7% | 0.00% | – |
Q4 2020 | $328,000 | +164.5% | 345,900 | +577.4% | 0.00% | – |
Q3 2020 | $124,000 | -54.2% | 51,061 | -28.4% | 0.00% | – |
Q2 2020 | $271,000 | +411.3% | 71,354 | +195.3% | 0.00% | – |
Q2 2018 | $53,000 | – | 24,162 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 242,237 | $511,000 | 0.10% |
CVI Holdings, LLC | 432,305 | $912,000 | 0.06% |
Virtu Financial LLC | 271,937 | $574,000 | 0.04% |
XTX Topco Ltd | 20,392 | $43,000 | 0.02% |
Newbridge Financial Services Group, Inc. | 7,000 | $15,000 | 0.01% |
Renaissance Technologies | 3,304,140 | $6,972,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 22,925 | $48,000 | 0.01% |
Bienville Capital Management, LLC | 28,379 | $60,000 | 0.01% |
Cutler Group LLC / CA | 223,100 | $116,000 | 0.01% |
Royal Fund Management, LLC | 15,000 | $31,000 | 0.01% |